Shattuck Labs Inc (STTK)

$7.74 +0.09 (1.18%)
Market Cap 578.20M
Revenue (ttm) 1.00M
Net Income (ttm) -48.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,881.00%
Debt to Equity Ratio 0.00
Volume 231,900
Avg Vol 557,914
Day's Range N/A - N/A
Shares Out 75.58M
Stochastic %K 64%
Beta 1.28
Analysts Strong Sell
Price Target $12.00

Company Profile

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also...

Industry: Biotechnology
Sector: Healthcare
Phone: 512 900 4690
Address:
500 West 5th Street, Suite 1200, Austin, United States
dick_dasterdly
dick_dasterdly Apr. 24 at 5:40 PM
$STTK Just relentless..
0 · Reply
dick_dasterdly
dick_dasterdly Apr. 22 at 10:39 AM
$STTK Over 769% growth in the past year. Wtf ? While you debate , I am cramming. And when you arrive, I'll welcome ya wit open arms. And then I'll ask ya.." where ya been" ?
0 · Reply
TheLaughingStock1
TheLaughingStock1 Apr. 17 at 12:23 PM
$STTK I got out recently, but since it has risen even more, I'm wondering if it's too risky to get back in now at this higher price!
1 · Reply
dick_dasterdly
dick_dasterdly Apr. 17 at 9:05 AM
$STTK Shhhh
0 · Reply
dick_dasterdly
dick_dasterdly Apr. 15 at 3:08 PM
$STTK Ohhhh myyy.. Load the fu*k up and wait till they discover us. The volume will come when their eyes open up . And then..
0 · Reply
dick_dasterdly
dick_dasterdly Apr. 13 at 7:59 PM
$STTK 640+ watchers..🤔 I am in here , at a fat position !!
0 · Reply
Doozio
Doozio Apr. 10 at 1:05 AM
$IWM $SMH $XBI how long until they go from fear to walking ENTA da weekend chasing $STTK s and $STOK s.
0 · Reply
NyseDayTrader
NyseDayTrader Apr. 9 at 2:06 PM
$STTK Jesus. I had the energizer bunny over. Just keeps going and going
0 · Reply
kubota2323
kubota2323 Apr. 6 at 7:51 PM
$STTK welp
0 · Reply
Doozio
Doozio Mar. 31 at 10:49 PM
If it ain’t gonna be XBI STOKs it will be $STTK s riding them huckleberries on the DLO 🐒🍌🧠⏰♾️
0 · Reply
Latest News on STTK
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights

Mar 5, 2026, 6:15 AM EST - 7 weeks ago

Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights

Shattuck Labs Announces Participation in Upcoming March Investor Conferences

Feb 25, 2026, 8:00 AM EST - 2 months ago

Shattuck Labs Announces Participation in Upcoming March Investor Conferences

Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium

Feb 6, 2026, 8:30 AM EST - 2 months ago

Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium

Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dec 15, 2025, 4:15 PM EST - 4 months ago

Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy

Dec 1, 2025, 4:33 PM EST - 5 months ago

Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy

Shattuck Labs to Participate in Upcoming December Investor Conferences

Nov 20, 2025, 8:00 AM EST - 5 months ago

Shattuck Labs to Participate in Upcoming December Investor Conferences

Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Nov 6, 2025, 4:30 PM EST - 6 months ago

Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel

Oct 2, 2025, 7:51 AM EDT - 7 months ago

Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel

Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors

Aug 26, 2025, 6:30 AM EDT - 8 months ago

Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors

Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease

Aug 21, 2025, 10:17 AM EDT - 8 months ago

Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease

Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Aug 14, 2025, 6:30 AM EDT - 9 months ago

Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million

Aug 5, 2025, 6:30 AM EDT - 9 months ago

Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million

Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism

Jul 2, 2025, 7:00 AM EDT - 10 months ago

Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 1, 2025, 4:20 PM EDT - 1 year ago

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

Apr 2, 2025, 5:00 PM EDT - 1 year ago

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

Mar 27, 2025, 7:00 AM EDT - 1 year ago

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

Feb 20, 2025, 9:00 AM EST - 1 year ago

Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

Feb 13, 2025, 4:30 PM EST - 1 year ago

Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis Congress

Feb 4, 2025, 7:00 AM EST - 1 year ago

Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis Congress

Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 4:59 PM EST - 1 year ago

Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

Jan 2, 2025, 7:00 AM EST - 1 year ago

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

Shattuck Labs, Inc. (STTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Oct 29, 2024, 10:00 AM EDT - 1 year ago

Shattuck Labs, Inc. (STTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Shareholders to Inquire about Securities Investigation

Oct 28, 2024, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Shareholders to Connect

Oct 27, 2024, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Investors to Connect

Oct 23, 2024, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Stockholders to Inquire about Securities Investigation

Oct 22, 2024, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Shattuck Labs, Inc. (STTK) and Encourages Investors to Learn More About the Investigation

Oct 21, 2024, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Shattuck Labs, Inc. (STTK) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Stockholders to Connect

Oct 20, 2024, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Stockholders to Connect

Shattuck Labs, Inc. (STTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Oct 16, 2024, 10:00 AM EDT - 1 year ago

Shattuck Labs, Inc. (STTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Shattuck Labs, Inc. (STTK) and Encourages Stockholders to Learn More About the Investigation

Oct 15, 2024, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Shattuck Labs, Inc. (STTK) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Investors to Inquire about Securities Investigation

Oct 14, 2024, 6:00 PM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Investors to Inquire about Securities Investigation

Shattuck Labs' stock craters as biotech scraps main product candidate after failed trial

Oct 1, 2024, 12:23 PM EDT - 1 year ago

Shattuck Labs' stock craters as biotech scraps main product candidate after failed trial

Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway

Oct 1, 2024, 6:30 AM EDT - 1 year ago

Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway

Shattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology Conference

Jul 30, 2024, 5:00 PM EDT - 1 year ago

Shattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology Conference

Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes

Jul 1, 2024, 6:00 AM EDT - 1 year ago

Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes

Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leuk

Jun 14, 2024, 6:00 AM EDT - 2 years ago

Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leuk

Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)

Jun 10, 2024, 7:30 AM EDT - 2 years ago

Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)

Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk My

Jun 6, 2024, 7:30 AM EDT - 2 years ago

Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk My

Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the E

May 14, 2024, 4:15 PM EDT - 2 years ago

Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the E

Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 2, 2024, 7:05 AM EDT - 2 years ago

Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024

Apr 9, 2024, 4:05 PM EDT - 2 years ago

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024

dick_dasterdly
dick_dasterdly Apr. 24 at 5:40 PM
$STTK Just relentless..
0 · Reply
dick_dasterdly
dick_dasterdly Apr. 22 at 10:39 AM
$STTK Over 769% growth in the past year. Wtf ? While you debate , I am cramming. And when you arrive, I'll welcome ya wit open arms. And then I'll ask ya.." where ya been" ?
0 · Reply
TheLaughingStock1
TheLaughingStock1 Apr. 17 at 12:23 PM
$STTK I got out recently, but since it has risen even more, I'm wondering if it's too risky to get back in now at this higher price!
1 · Reply
dick_dasterdly
dick_dasterdly Apr. 17 at 9:05 AM
$STTK Shhhh
0 · Reply
dick_dasterdly
dick_dasterdly Apr. 15 at 3:08 PM
$STTK Ohhhh myyy.. Load the fu*k up and wait till they discover us. The volume will come when their eyes open up . And then..
0 · Reply
dick_dasterdly
dick_dasterdly Apr. 13 at 7:59 PM
$STTK 640+ watchers..🤔 I am in here , at a fat position !!
0 · Reply
Doozio
Doozio Apr. 10 at 1:05 AM
$IWM $SMH $XBI how long until they go from fear to walking ENTA da weekend chasing $STTK s and $STOK s.
0 · Reply
NyseDayTrader
NyseDayTrader Apr. 9 at 2:06 PM
$STTK Jesus. I had the energizer bunny over. Just keeps going and going
0 · Reply
kubota2323
kubota2323 Apr. 6 at 7:51 PM
$STTK welp
0 · Reply
Doozio
Doozio Mar. 31 at 10:49 PM
If it ain’t gonna be XBI STOKs it will be $STTK s riding them huckleberries on the DLO 🐒🍌🧠⏰♾️
0 · Reply
TMC101
TMC101 Mar. 30 at 4:04 PM
$STTK In🤑
0 · Reply
Quantum_Capital_LLC
Quantum_Capital_LLC Mar. 16 at 5:36 PM
$STTK The fight will be around this 7.50 area. If it can break through, we can see 15 to 16 after. Glta.
1 · Reply
TheLaughingStock1
TheLaughingStock1 Mar. 9 at 11:19 AM
$STTK I only put in a little on this a while back, but now wishing I went big on it! It keeps outperforming and everytime I anticipate the dip, it climbs further! Now I'm afraid to average up!
1 · Reply
S2K_TP
S2K_TP Mar. 7 at 5:46 AM
$STTK king of momentum play. Pt: 10+
0 · Reply
StockScanners
StockScanners Mar. 7 at 5:32 AM
$STTK keep watch if this holds above 5.70
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 6 at 3:08 PM
$STTK I said 'Nest' because that's how we say Next in my country.. Don't laugh at me 👊👊
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 5 at 7:08 PM
$STTK Sorry I meant $5.00 not $6.00 hit either way.. Here we are.... With more money 💰 💰
0 · Reply
focafoca99
focafoca99 Mar. 5 at 4:31 PM
$STTK filed an 8-K dated March 5, creating a fresh disclosure point for biotech traders scanning event risk.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 5 at 3:30 PM
$STTK Q4 '25 Earnings Results & Recap Shattuck Labs Inc expects to complete enrollment in its Phase 1 clinical trial for SL-325 in Q2 2026 and initiate a Phase 2 clinical trial in CD patients in Q3 2026, with current capital sufficient through 2029.
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 5 at 2:41 PM
$STTK Moving up towards $6.00 and we have another overnight swing winner.. Keep it going 39 straight 🚨🚨
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Mar. 5 at 2:35 PM
$STTK Earnings looked good... $4.73 Nest to break 🚨🚨
2 · Reply
CaptainStockWolf
CaptainStockWolf Feb. 25 at 3:05 PM
$STTK in
0 · Reply